Indian Startups Raise $1.1 Bn This Week; CRED Leads With $900 Mn Series H

Sixteen deals totaling $1.1 Bn flowed into Indian startups, led by CRED's $900 Mn Series H and Square Yards' $95 Mn unicorn round. Honasa (Mamaearth parent) is acquiring a stake in Fluence Pharma for ₹135 Cr, while Turtlemint's ₹883 Cr IPO closed 1.2X subscribed and Zypp Electric is prepping a $200 Mn listing.

— Source publishedSat, 27 Jun, 2026, 09:00 IST·First seen Sat, 27 Jun, 2026, 09:04 IST·Source Inc42

What happened

Cred · Indian startups raised $1.1 Bn this week led by CRED's $900 Mn Series H. Consumer-relevant moves: Honasa (Mamaearth) acquiring Fluence Pharma for ₹135

Key facts

  • $1.1 Bn raised across 16 deals
  • CRED $900 Mn Series H
  • Square Yards $95 Mn (131st unicorn)
  • Honasa acquiring Fluence Pharma stake for ₹135 Cr
  • Turtlemint ₹883 Cr IPO 1.2X subscribed
  • Zypp Electric targeting $200 Mn IPO

Why this matters

Honasa's ₹135 Cr Fluence Pharma stake signals strategic vertical roll-ups in beauty-to-pharma adjacencies—evaluate similar tuck-in targets where category convergence creates distribution leverage.

What to watch

  • CRED valuation disclosure (flat at $6.4B = neutral; down round = sector reset)
  • Turtlemint listing day price action and GMP trajectory
  • Zypp Electric DRHP pricing band announcement
  • Honasa Q3 earnings commentary on M&A pipeline
  • Weekly deal count holding above 12 for next 3 weeks (breadth signal)
  • Any secondary tender announcements from Tier-1 funds (Accel, Peak XV, Lightspeed)
  • Pull CRED's Series H term sheet structure — liquidation prefs, ratchets, secondary component — to gauge whether $900M is fresh primary or founder/early-investor exit
  • Build Turtlemint Day-1 pricing model; if it breaks issue, downgrade Zypp listing probability to 50/50
  • Map Honasa's cash position vs. Fluence deal size; flag whether this signals more M&A capacity or one-off
  • Track Square Yards comps (PropTiger, NoBroker) for valuation read-through on the new unicorn
  • Survey 5-7 Series B/C founders on term sheet velocity vs. Q3 to confirm/deny breadth thesis

Also reported by